Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Coll Antropol ; 34(4): 1461-5, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21874740

RESUMO

We are presenting a case of isolated fulminant meningococcal sepsis with two and a half year old child. Initial symptoms were obscure and common to many medical conditions, but also previously described as symptoms of meningococcal sepsis. Unrecognizing the seriousness of the condition child died at home, within few hours after examination and discharge from the hospital. Autopsy and microbiological findings unquestionably proved that the child died from septic shock caused by fulminant meningococcal sepsis.


Assuntos
Bacteriemia/diagnóstico , Infecções Meningocócicas/diagnóstico , Bacteriemia/patologia , Pré-Escolar , Feminino , Humanos , Infecções Meningocócicas/patologia
2.
Coll Antropol ; 32(1): 103-7, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18494194

RESUMO

The aim of this study was to present our diagnostic and therapeutic experience with antiphospholipide syndrome (APS) and vascular thrombosis. Ninety-nine patients with positive antiphospholipide antibodies (aPL) and vascular thrombosis were included in the study: forty patients, according to clinical classification criteria, had primary antiphospholipide syndrome (PAPS), and fifty-nine patients had secondary antiphospholipide syndrome (SAPS). In PAPS group, 82.5% of the patients were LA-positive, 37.5% of the patients were IgG aCL-positive, 27.5% of the patients were IgM aCL-positive, and 15% of the patients were IgG antibeta2GPI-positive. In SAPS group, 61% of the patients were LA-positive, 50.8% of the patients were IgG aCL-positive, and 47.5% of the patients were IgM aCL-positive. Administered therapy was low molecular weight heparin (LMWH) throughout 7 days, followed by warfarin with prothrombin time maintained between 2.0 and 3.0 INR.


Assuntos
Síndrome Antifosfolipídica/complicações , Trombose/etiologia , Anticorpos Anticardiolipina/sangue , Síndrome Antifosfolipídica/imunologia , Feminino , Humanos , Imunoglobulinas/sangue , Inibidor de Coagulação do Lúpus/sangue , Masculino , Pessoa de Meia-Idade , Trombose/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...